17th EVF London Industry Sponsored Symposia

Industry Sponsored Symposia

 

Thursday 7 July 2016

11:00-12:00 Didactic Session 1: Sulodexide (Supported by an educational grant from Alfa Wassermann)

Chairmen: Andrew Nicolaides (Cyprus), Guiseppe Maria Andreozzi (Italy)

11:00 Biomarkers in chronic venous disease and deep venous disease. Ferdinando Mannello (Italy)
11:15 Sulodexide in chronic venous disease and deep venous disease recurrence. Tomasz Urbanek (Poland)
11:30 Pharmacological rationale behind the clinical effects of Sulodexide. Jawed Fareed (USA)
11:45 Discussion. Moderator: Andrew Nicolaides (Cyprus)

 

 

Thursday 7 July 2016

16:30-17:30 Didactic Session 4: Lymphoedema (Supported by an educational grant from Sigvaris)

Chairmen: Christine Moffat (UK), Sophie Renton (UK)

16:30-16:45 The new classification of primary lymphatic dysplasias and prognosis. Sohar Mansour (UK)
16:45-17:00 The Management of lymphedema including the patient journey. Tracy Green (UK)
17:00-17:15 The use of compression therapy and IPC in the management of lymphedema. Christine Moffat (UK)
17:15-17:30 Discussion

 

 

Friday 8 July 2016

11:00-12:00 Didactic Session 5: The place of ruscus extract + HMC + VitC in the management of chronic venous disease (Supported by an educational grant from Pierre Fabre)

Chairmen: Andrew Nicolaides (Cyprus), Pavel Poredos (Slonenia)

11:00-11:15 Muscarinic receptors in chronic venous disease and the effect of Ruscus. Eliete Bouskela (Brazil)
11:15-11:30 Chronic venous disease pathophysiology update. Arkadiusz Jawien (Poland)
11:30-11:45 Update on Ruscus extract + HMC + VitC comprehensive mode of action and efficacy. Francois-André Allaert (France)
11:45-12:00 Panel Discussion and Conclusions.

 

Comments are closed.